Abstract 2398: Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinicDarren Hodgson, Mark J. O’Connor, Lenka Oplustilova et al.|Cancer Research|2014Cited by 7